VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
+3.55%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$48M
AUM Growth
+$48M
(-0.74%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
CRISPR Therapeutics
CRSP
$4.71B
| $22.5M | 47.01% | 498,558 | – | – |
|
|
GRTS
2
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $9.9M | 20.64% | 3,561,150 | – | – |
|
3
Passage Bio
PASG
$22.7M
| $4.75M | 9.9% | 4,959,769 | – | – |
|
|
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
| $4.74M | 9.88% | 543,753 | – | – |
|
5
Adverum Biotechnologies
ADVM
$64.6M
| $3.64M | 7.58% | 5,068,233 | – | – |
|
6
Aligos Therapeutics
ALGS
$73.3M
| $2.03M | 4.23% | 2,320,381 | – | – |
|
|
UTRS
7
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
| $367K | 0.77% | 1,673,700 | – | – |
|